Martin Åmark
Since 2015
Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including Life Science and pharmaceuticals.
Shares: 154,646
Warrants: 24,000
Siavash Bashiri
Since 2015
Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.
Shares: 110,970
Warrants: 7,000
Anette Lindqvist
Since 2021
Anette Lindqvist has a degree in Business Administration from Gothenburg University of Economics. She has more than 25 years’ experience from the Life Science sector having held a number of Senior Finance & Business roles such as Global Clinical Finance Director at AstraZeneca, Head of Business Control at Swedish Orphan Biovitrum, Global CFO, SVP Finance Getinge Infection Control & Global CFO Operations & Supply Chain Mölnlycke Healthcare.
Shares: 2,000
Warrants: –
Dr. David Vikström
Since 2014
David Vikström is the CTO of Xbrane Bioscience. He has a Ph.D. in expression and targeting of proteins in E. coli. He joined Xbrane in 2010 and successfully developed new technologies and strains for vaccine candidates. He is currently heading the development of Xbrane’s new expression systems to be able to take the expression in E. coli to new levels.
Shares: 32,518
Warrants: 24,000
Anders Wallström
Since 2019
Anders Wallström holds a M. Sc. in Biotechnology from Royal Institute of Technology in Stockholm. He has more than 20 years of experience from process development, manufacturing and validation at SOBI and Biovitrum. Furthermore, he has significant experience from coordinating contract manufacturers for commercial products for both small molecule and biotech products.
Shares: 4,503
Warrants: –
Maria Edebrink
Since 2019
Maria Edebrink holds a M. Sc. in Chemistry from Stockholm University. She has 28 years of experience from Pharmaceutical Development and CMC Regulatory Affairs working for AstraZeneca, Galderma and Medivir. Her experience covers biotech products, small molecules, medical devices and cosmetics from early to late stage development through to commercial manufacturing.
Shares: 7,105
Warrants: –
Xiaoli Hu
Since 2020
Xiaoli has a Medical Doctor degree from Shanghai Jiao Tong University as well as a Ph.D in Medical Science from Karolinska Institutet. Xiaoli has experience in business development from the pharmaceutical industry, most recently as Head of Business Development at Affibody, where she led the work on the commercial partnership agreement of USD 650 million with Alexion and the co-development agreement with GE Healthcare. Prior to that, Xiaoli spent almost four years on HealthCap, a leading Nordic health and healthcare investor.
Shares: –
Warrants: –
Nina Ivers
Since 2020
Nina Ivers holds a M. Sc. in Pharmacy and has studied Human Resources Mangagement at Uppsala and Stockholm University. She has more than 25 years of experience from different business roles and areas in life science companies like Astra, Johnson & Johnson and Swedish Orphan Biovitrum. She has experience from leading positions in marketing and sales as well as HR, most recently in a Global HR role at Sobi where she contributed to the growth of the company and development of the HR function.
Shares: 3,300
Warrants: –
Erik Domines
Since 2021
Erik Domines holds a Bachelor’s degree in law from Stockholm University and a General Counsel mini-MBA. He has extensive experience as in-house counsel in the Life Science sector and various projects in legal operations. Previous position as General Counsel at Recipharm.
Shares: 900
Warrants: –
